Medgenics, Inc. Information

Medgenics is a clinical-stage biopharmaceutical company developing an innovative and proprietary platform technology - a biological "Biopump" - which allows patients to produce, within their bodies and on a long-term basis, their own natural human protein therapy for the treatment of a range of chronic diseases, such as anemia and hepatitis C.

Website	http://www.medgenics.com
Ticker	MDGN
Revenue	$18.4 million
Employees	14 (2 on RocketReach)
Founded	2000
Address	435 DEVON PARK Dr., Ste. 715, Wayne, Pennsylvania 19087, US
Phone	+1 610-254-4201
Technologies	JavaScript , HTML , Microsoft Outlook +6 more (view full list)
Industry	Biotechnology, Pharmaceuticals, Healthcare
Web Rank	38 Million
Keywords	Clinical Stage, Drug Delivery, Biological Therapeutics, Protein Therapeutics, Extended Release, Biotechnology, Pharmaceutical Technology, Human Proteins, Biologics, Therapeutic Proteins, Sustained Release, Drug Development, Biomedical Engineering, Gene Therapy, Innovative Medicines, Treatment Development, Patient Care
Competitors	Amgen, GSK, Biogen, Regeneron, Sangamo Therapeutics, Inc., Spark Therapeutics, Inc., CRISPR Therapeutics, Alnylam Pharmaceuticals, Novartis, Receptos, a wholly-owned subsidiary of Celgene +47 more (view full list)
SIC	SIC Code 283 Companies, SIC Code 28 Companies
NAICS	NAICS Code 541 Companies, NAICS Code 325 Companies, NAICS Code 54 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 5417 Companies, NAICS Code 32541 Companies